ClinSync
  • Home
  • About Us
    • Core Competencies
    • Vision and Mission
    • ClinSync Values
  • Services
    • Oncology and Special Population services
    • Early Stage Clinical Development
      • Brief Overview
      • Cardiac Safety/ TQT studies
      • Facilities in General
      • Phase I
    • Late Stage Clinical Development
      • Brief Overview
      • Data Management
      • Site Management & Monitoring
      • Program, Project & Study Management
      • Temporary Staffing/Flexible Sourcing Solutions
    • Bioanalytical Services
    • DMPK Services
    • Toxicology
    • Medical Writing
    • Biostatistics
    • Quality Assurance & Regulatory Services
    • Pharmaco Vigilance Services
  • International Operations
  • Collaborations
  • Career
  • Contact
  • Search
  • Menu

ClinSync

We bring more advantage to your Cardiac Safety/ TQT studies

We optimize protocol design, fulfill requirements for TQT studies, support Phase I CPUs in intense ECG studies with PK-PK analysis, and ensure accurate regulatory submissions. ClinSync has the right medical and scientific expertise, technology and process & compliance to provide highest quality of data to our Sponsor’s and CRO partners who depend on, study after study.

Our Expertise:

Highly experienced cardiologists to review, analyze and adjudicate each ECG

Expert QT reporting reviewed by cardiologists and statisticians

ECG project managers as your dedicated single point of contact

24/7 site support including investigator / site helpline (for multicentre studies)

Hands on experience of handling critical molecules for cardiac safety

Our Technology:

12-lead modem-based digital ECG and 12-lead Holter

On-screen analysis and interval measurement in FDA-compliant XML format

Your choice of digital ECG collection technologies (Eg: Philips Muse Server) & Site Training

Web portal for real-time access to ECG data

Our Process and Compliance:

Standard Operating Procedure in compliance to guidelines

Strict ICH E14 compliance

ACC/AMA/ESC 2006 Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Society of Cardiology, Eurospace 2006) 8, 746-837

  • Bioanalytical Services
  • Biostatistics
  • DMPK Services
  • Early Stage Clinical Development
    • Brief Overview
    • Cardiac Safety/ TQT studies
    • Facilities in General
    • Phase I
  • Late Stage Clinical Development
    • Brief Overview
    • Data Management
    • Program, Project & Study Management
    • Site Management & Monitoring
    • Temporary Staffing/Flexible Sourcing Solutions
  • Medical Writing
  • Oncology and Special Population services
  • Pharmaco Vigilance Services
  • Quality Assurance & Regulatory Services
  • Toxicology
Scroll to top